Matches in SemOpenAlex for { <https://semopenalex.org/work/W1591726497> ?p ?o ?g. }
- W1591726497 endingPage "no" @default.
- W1591726497 startingPage "no" @default.
- W1591726497 abstract "Hasselbalch B, Eriksen JG, Broholm H, Christensen IJ, Grunnet K, Horsman MR, Poulsen HS, Stockhausen M-T, Lassen U. Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan. APMIS 2010; 118: 585–94. Several recent studies have demonstrated a beneficial effect of anti-angiogenic treatment with the vascular endothelial growth factor-neutralizing antibody bevacizumab in recurrent high-grade glioma. In the current study, immunohistochemical evaluation of biomarkers involved in angiogenesis, hypoxia and mediators of the epidermal growth factor receptor (EGFR) pathway were investigated. Tumor tissue was obtained from a previous phase II study, treating recurrent primary glioblastoma multiforme (GBM) patients with the EGFR inhibitor cetuximab in combination with bevacizumab and irinotecan. Of the 37 patients with available tumor tissue, 29 were evaluable for response. We concurrently performed immunohistochemical stainings on tumor tissue from 21 GBM patients treated with bevacizumab and irinotecan. We found a tendency of correlation between the hypoxia-related markers, indicating that they share the same regulatory mechanisms. None of the EGFR-related biomarkers showed any significant correlations with each other. None of the biomarkers tested alone or in combination could identify a patient population likely to benefit from bevacizumab and irinotecan, with or without the addition of cetuximab. There is still an urgent need for one or more reliable and reproducible biomarkers able to predict the efficacy of anti-angiogenic therapy." @default.
- W1591726497 created "2016-06-24" @default.
- W1591726497 creator A5004172331 @default.
- W1591726497 creator A5007297826 @default.
- W1591726497 creator A5019129343 @default.
- W1591726497 creator A5029993010 @default.
- W1591726497 creator A5048852019 @default.
- W1591726497 creator A5063977962 @default.
- W1591726497 creator A5077199450 @default.
- W1591726497 creator A5087170219 @default.
- W1591726497 creator A5088517672 @default.
- W1591726497 date "2010-06-01" @default.
- W1591726497 modified "2023-10-11" @default.
- W1591726497 title "Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan" @default.
- W1591726497 cites W1959628099 @default.
- W1591726497 cites W1969656908 @default.
- W1591726497 cites W1970941198 @default.
- W1591726497 cites W1973541913 @default.
- W1591726497 cites W1976935268 @default.
- W1591726497 cites W1990923495 @default.
- W1591726497 cites W2000624133 @default.
- W1591726497 cites W2002265561 @default.
- W1591726497 cites W2002727873 @default.
- W1591726497 cites W2011810742 @default.
- W1591726497 cites W2013624093 @default.
- W1591726497 cites W2020021293 @default.
- W1591726497 cites W2033847281 @default.
- W1591726497 cites W2037761545 @default.
- W1591726497 cites W2052182008 @default.
- W1591726497 cites W2054169323 @default.
- W1591726497 cites W2054491389 @default.
- W1591726497 cites W2059276755 @default.
- W1591726497 cites W2060346337 @default.
- W1591726497 cites W2069698188 @default.
- W1591726497 cites W2070705072 @default.
- W1591726497 cites W2075054245 @default.
- W1591726497 cites W2085609942 @default.
- W1591726497 cites W2093783077 @default.
- W1591726497 cites W2095999479 @default.
- W1591726497 cites W2096287682 @default.
- W1591726497 cites W2104743043 @default.
- W1591726497 cites W2105100844 @default.
- W1591726497 cites W2110492979 @default.
- W1591726497 cites W2129873928 @default.
- W1591726497 cites W2132697290 @default.
- W1591726497 cites W2143739956 @default.
- W1591726497 cites W2149485140 @default.
- W1591726497 cites W2150638747 @default.
- W1591726497 cites W2152931086 @default.
- W1591726497 cites W2159789252 @default.
- W1591726497 cites W2170212327 @default.
- W1591726497 cites W2170367762 @default.
- W1591726497 cites W217147462 @default.
- W1591726497 cites W2338264812 @default.
- W1591726497 doi "https://doi.org/10.1111/j.1600-0463.2010.02631.x" @default.
- W1591726497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20666740" @default.
- W1591726497 hasPublicationYear "2010" @default.
- W1591726497 type Work @default.
- W1591726497 sameAs 1591726497 @default.
- W1591726497 citedByCount "15" @default.
- W1591726497 countsByYear W15917264972013 @default.
- W1591726497 countsByYear W15917264972014 @default.
- W1591726497 countsByYear W15917264972015 @default.
- W1591726497 countsByYear W15917264972016 @default.
- W1591726497 countsByYear W15917264972017 @default.
- W1591726497 countsByYear W15917264972018 @default.
- W1591726497 countsByYear W15917264972022 @default.
- W1591726497 countsByYear W15917264972023 @default.
- W1591726497 crossrefType "journal-article" @default.
- W1591726497 hasAuthorship W1591726497A5004172331 @default.
- W1591726497 hasAuthorship W1591726497A5007297826 @default.
- W1591726497 hasAuthorship W1591726497A5019129343 @default.
- W1591726497 hasAuthorship W1591726497A5029993010 @default.
- W1591726497 hasAuthorship W1591726497A5048852019 @default.
- W1591726497 hasAuthorship W1591726497A5063977962 @default.
- W1591726497 hasAuthorship W1591726497A5077199450 @default.
- W1591726497 hasAuthorship W1591726497A5087170219 @default.
- W1591726497 hasAuthorship W1591726497A5088517672 @default.
- W1591726497 hasConcept C121608353 @default.
- W1591726497 hasConcept C126322002 @default.
- W1591726497 hasConcept C143998085 @default.
- W1591726497 hasConcept C167734588 @default.
- W1591726497 hasConcept C204232928 @default.
- W1591726497 hasConcept C2776694085 @default.
- W1591726497 hasConcept C2777025900 @default.
- W1591726497 hasConcept C2777802072 @default.
- W1591726497 hasConcept C2778227246 @default.
- W1591726497 hasConcept C2779438470 @default.
- W1591726497 hasConcept C2779998722 @default.
- W1591726497 hasConcept C2780259306 @default.
- W1591726497 hasConcept C2780394083 @default.
- W1591726497 hasConcept C502942594 @default.
- W1591726497 hasConcept C526805850 @default.
- W1591726497 hasConcept C71924100 @default.
- W1591726497 hasConceptScore W1591726497C121608353 @default.
- W1591726497 hasConceptScore W1591726497C126322002 @default.
- W1591726497 hasConceptScore W1591726497C143998085 @default.
- W1591726497 hasConceptScore W1591726497C167734588 @default.